What ethnicity is commonly affected by sickle cell disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ethnicity Most Commonly Affected by Sickle Cell Disease

Sickle cell disease most commonly affects people of African or African-Caribbean descent, with 98% of patients registered in the UK National Haemoglobinopathy Registry being of African or Caribbean background. 1

Epidemiology and Global Distribution

Sickle cell disease (SCD) is one of the most common serious inherited single gene disorders worldwide. The distribution varies significantly by geographic region and ethnic background:

  • African/African-Caribbean: The vast majority of SCD cases occur in people with African ancestry. In the UK, 98% of registered patients are of African or Caribbean background 1
  • Mediterranean: SCD is also seen in families originating from Mediterranean countries 1
  • Middle Eastern: Individuals from the Middle East have higher prevalence than the general population 1
  • Indian subcontinent: SCD is present in families from India and the southern/eastern Mediterranean 1

Geographic Distribution in the UK

  • Approximately two-thirds of patients with SCD in the UK live in London
  • The remaining one-third live in cities in the North West, West Midlands, East Midlands, or Yorkshire and Humber 1

Genetic and Evolutionary Context

The high prevalence of sickle cell trait in certain populations is linked to evolutionary pressure from malaria:

  • The HbS mutation in the β-globin gene provides protection against malarial infection in heterozygous carriers (sickle cell trait) 1
  • This evolutionary advantage has maintained the mutation at high frequencies in malaria-endemic regions, particularly in sub-Saharan Africa 1
  • Similar selective pressure has influenced other genetic adaptations to malaria in African, Mediterranean and Asian populations, such as G6PD variations 1

Global Burden

  • An estimated 300,000-400,000 infants are born with SCD globally each year 2, 3
  • The majority of these births occur in sub-Saharan Africa 2, 3
  • In the US, approximately 100,000 people live with SCD 2
  • In the UK, there are approximately 14,000 patients with SCD 1

Clinical Implications of Ethnicity

Understanding the ethnic distribution of SCD is important for:

  1. Screening programs: Many countries have implemented universal newborn screening, but this remains challenging in low-income, high-burden settings 3
  2. Genetic counseling: Particularly important for individuals from high-risk ethnic backgrounds
  3. Healthcare resource allocation: In areas with significant populations of affected ethnic groups

Common Pitfalls and Caveats

  • Assuming SCD only affects Black populations: While most common in those of African descent, SCD also affects people from Mediterranean, Middle Eastern, and South Asian backgrounds
  • Overlooking mixed ancestry: With increasing multiethnic partnerships, there are changing patterns in SCD distribution, including increased numbers of variant forms like Hb SE disease 4
  • Confusing trait with disease: Sickle cell trait (carrier status) is much more common than sickle cell disease and is present in approximately 240,000 healthy carriers in the UK 1
  • Failing to screen appropriately: Universal screening of newborns from at-risk ethnic backgrounds is recommended to enable early diagnosis and preventive care 5

Understanding the ethnic distribution of SCD is crucial for appropriate screening, early diagnosis, and optimal management to reduce morbidity and mortality in affected populations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sickle cell disease.

Nature reviews. Disease primers, 2018

Research

[Sickle cell anemia: experience in a center].

Anales de pediatria (Barcelona, Spain : 2003), 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.